MediPharm Labs management team changes
Perth, Feb 8, 2019 AEST (ABN Newswire) - MMJ Group Holdings Limited (
ASX:MMJ) (2P9:FRA) (MMJJF:OTCMKTS) attaches a copy of a recent news release by MediPharm Labs Inc ("MediPharm Labs") (CVE:LABS) (MLCPF:OTCMKTS) announcing management team changes.
MMJ owns approximately 4.4 million shares for a 4.3% shareholding (at a cost of CAD$0.85 per share) and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs.
To view the news release, please visit:
http://abnnewswire.net/lnk/2Y275520
About MMJ Group Holdings Ltd
MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: https://www.mmjphytotech.com.au/investors/
| ||
|
